Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Anticoagulant therapy.

American Journal of Surgery

|October 8, 1985

Summary

This summary is machine-generated.

Anticoagulant therapy for venous thromboembolism is crucial for reducing clot recurrence. Extended treatment duration and careful monitoring minimize risks and improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Surgical aspects of splenic disease and lymphoma.

Current problems in surgery·1998

Same author

The spleen and splenectomy.

Surgery, gynecology & obstetrics·1991

Same author

Iatrogenic splenic injury.

American journal of surgery·1990

Same author

Splenectomy for massive splenomegaly.

Surgery, gynecology & obstetrics·1989

Same author

Some factors affecting phencyclidine biotransformation by human liver and placenta.

Drug metabolism and disposition: the biological fate of chemicals·1989

Same author

Splenectomy for cytopenias associated with systemic lupus erythematosus.

American journal of surgery·1988

Same journal

High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

American journal of surgery·2026

Same journal

Women with firearm injuries: A multicenter mixed-methods study.

American journal of surgery·2026

Same journal

SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

American journal of surgery·2026

Same journal

Using Dr. Google and AI to stay informed.

American journal of surgery·2026

Same journal

Revealing the sex divide: Primary hyperparathyroidism across the American population.

American journal of surgery·2026

Same journal

Pressure points: A pilot study using the NASA-TLX tool to measure the intensity of Acute care surgery work.

American journal of surgery·2026

See all related articles

Area of Science:

Pharmacology
Clinical Medicine
Hematology

Background:

Venous thromboembolism (VTE) necessitates effective anticoagulant management.
Current therapeutic strategies involve ongoing debate regarding optimal drug dosage, monitoring, and treatment duration.
Balancing efficacy and safety is paramount in managing VTE.

Purpose of the Study:

To review key aspects of anticoagulant therapy for VTE.
To discuss controversial treatment parameters including dosage, monitoring, and duration.
To provide guidance on minimizing thromboembolic and hemorrhagic complications.

Main Methods:

Literature review focusing on pharmacology and clinical management of anticoagulation for VTE.
Analysis of treatment strategies concerning drug dosage, laboratory monitoring, and therapy duration.

Related Experiment Videos

Evaluation of factors influencing thromboembolic and hemorrhagic complication rates.

Main Results:

Extending anticoagulant therapy to at least 4 months post-discharge reduces VTE recurrence.
Prolonged treatment may be indicated for patients experiencing recurrent VTE.
Minimizing bleeding risks requires diligent laboratory monitoring and awareness of drug interactions.

Conclusions:

Optimal duration of anticoagulant therapy for VTE is essential for preventing recurrence.
Careful patient monitoring and management of drug-related factors are key to safe and effective anticoagulation.
Individualized treatment plans are necessary, especially for patients with recurrent VTE.